Abstract
Background and Importance Primary leptomeningeal melanoma (PLM) is highly malignant and exceedingly rare. Due to its rarity, diagnostic and treatment paradigms have been slow to evolve. We report the first case of a PLM that mimics a cervical spine meningioma and then discuss the current clinical, radiologic, and pathologic diagnostic methodologies as well as expected outcomes related to this disease. Clinical Presentation A 54-year-old woman presented a dural-based extramedullary solid mass ventral to the C2-C3 spinal cord causing spinal cord compression without cord signal changes, characteristic of meningioma. Intraoperative microscopic inspection revealed numerous black spots littering the surface of the dura; the tumor itself was yellow in appearance and had a soft consistency. Pathologic analysis of the specimen revealed a malignant melanin-containing tumor. No primary site was found, so a diagnosis of primary leptomeningeal melanoma was made, and the patient subsequently received interferon therapy. To date (2 years postoperatively), no local or systemic recurrence of the tumor has been identified. Conclusion As with most rare tumors, case reports constitute the vast majority of references to PLM. Only an increased awareness and an extensive report of each individual case can help diagnose and clarify the nature of PLM. Clinicians need to be aware of such malignant conditions when diagnosing benign tumoral lesions of the spine such as meningiomas. melanocytoma and meningioma) that can be mimicked by PLM. [5] [6] [7] [8] [9] [10] [11] [12] [13] Meningioma is one of the most common neurosurgical conditions, constituting > 20% of primary brain tumors.
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Spinal PLM represents both diagnostic and management challenges.
14, 15 We present the rare case of PLM in the ventral cervical spine, and then discuss the diagnosis and management of this lesion as a mimicker of meningioma.
Clinical Presentation Clinical Summary
A patient in her sixth decade presented with 6 months of intermittent dizziness, slight weakness of the lower extremities, and foot paraesthesias, as well as 4 months of urge incontinence. Apart from essential hypertension, her previous medical history was negative. Physical examination revealed bilateral upper and lower extremity hyperreflexia without obvious paresis, cerebellar signs, or oculovestibular abnormalities. Magnetic resonance imaging (MRI) detected a dural-based extramedullary solid mass ventral to the C2-C3 spinal cord causing spinal cord compression without cord signal changes (►Fig. 1A-C). The tumor appeared isointense on T1-and hyperintense on T2-weighted images with homogeneous contrast enhancement, characteristic of meningioma. Communicating hydrocephalus was also noted. Surgical resection was planned for a suspected ventral spine meningioma.
Operation and Postoperative Course
A right-sided posterolateral approach was performed to expose the lesion. Intraoperative microscopic inspection revealed numerous black spots littering the surface of the dura; the tumor itself was yellow in appearance and had a soft consistency (►Fig. 2). Gross total resection was achieved, and postoperative MRI displayed no residual tumor or contrast enhancement (►Fig. 1D). Postoperatively, the patient's symptoms resolved completely, and she had an uncomplicated hospital course. Pathologic analysis of the specimen revealed a malignant melanin-containing tumor, which led to a thorough organ system evaluation to find the primary lesion. No primary site was found, so a diagnosis of primary leptomeningeal melanoma was made and the patient subsequently received interferon therapy. Two years postoperatively, no local or systemic recurrence of the tumor has been identified.
Discussion Clinical Evaluation
PLM is not associated with specific clinical symptoms. 16, 17 In the present case, the patient's main complaints were due to tumor location and size, as others have also documented. 
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Communicating hydrocephalus with associated intracranial hypertension seem to be common clinical features of melanocytic lesions in the CNS. 27 The present case is radiographically atypical for PLM in that its MRI characteristics more resemble the appearance of amelanotic melanoma without a hemorrhagic component (T1 isointense and T2 hyperintense), which is similar to the appearance of meningioma. 7, 10, 18 The lack of melanin signal on the MRI in this case may be explained by the atypical gross appearance of the tumor (i.e., yellow with black spots on the dura as opposed to a deep brown or black-appearing mass, due to high levels of melanin). The absence of an additional tumor source in conjunction with the pathologic findings just described led to the diagnosis of a solitary PLM in this patient.
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Treatment and Prognosis
Although PLM has a better prognosis than metastatic melanoma, 10, 18 it is highly malignant and median survival is < 6 months. 3, 15 Diffuse PLM has a worse prognosis than nodular PLM. 17, 21, 36 Gross total resection (GTR) of solid lesions is usually performed and has been assumed to contribute to prolonged survival in many cases, although not all. 2, 3, 5, 8, 10, 11, 13, 14, 29 A possible explanation for the exceptionally poor outcomes, despite successful GTR, may be misdiagnosis of PLM in the setting of actual metastatic melanoma, where the primary tumor (for instance, on the Leptomeningeal Melanoma Mimics Spinal Meningioma Marx et al. e95
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skin) spontaneously regressed and went undetected. 7 These points emphasize the need for a multimodal approach including radiotherapy and intrathecal chemotherapy as has been suggested. 3, 23, 31, 43, 45 The patient in the present case had a GTR followed by interferon therapy. To date (2 years after surgery), there are no clinical or radiologic signs of tumor recurrence. We did not treat the patient's communicating hydrocephalus for two reasons: (1) the patient was symptom free after surgery, and (2) there is a risk of spreading malignant cells into the peritoneal cavity through CSF diversion with a ventriculoperitoneal shunt. 
